Helius Medical Technologies, Inc.

Contributing Author

Recent Articles by Helius Medical Technologies, Inc.

Jul-21	Helius Announces Positive Outcome of the Portable Neuromodulation Stimulator PoNS Stroke Registrational Program and Upcoming Submission to FDA Under Breakthrough Designation HSDT GlobeNewswire
Jul-09	Helius Medical Technologies, Inc. Compliant with Nasdaq's Continued Listing Requirements HSDT GlobeNewswire
Jun-27	Helius Medical Technologies Announces Reverse Stock Split HSDT GlobeNewswire
Jun-16	Helius Medical Technologies, Inc. Announces Claim Authorization by CignaHealth, for its Portable Neuromodulation Stimulator (PoNS) Device HSDT GlobeNewswire
Jun-12	Positive PoNSTEP Study Results Presented at Consortium of Multiple Sclerosis Centers Annual Meeting HSDT GlobeNewswire
Jun-11	Helius Medical Technologies, Inc. Announces Authorized Claim for Payment by Major Healthcare Payer for its Portable Neuromodulation Stimulator (PoNS) Device HSDT GlobeNewswire
Jun-04	Helius Medical Technologies Announces Pricing of $9.1 Million Public Offering HSDT GlobeNewswire
Jun-04	Helius Medical Technologies, Inc. Compliant with Nasdaq Bid Price Rule Listing Criteria HSDT GlobeNewswire
May-20	Helius to Spotlight Study Confirming Improved Long-Term Outcomes from Adherence to PoNS Therapy at CMSC Annual Meeting HSDT GlobeNewswire
May-12	Helius Medical Technologies, Inc. Announces Reimbursement by Major Healthcare Provider for its Portable Neuromodulation Stimulator (PoNS) Device HSDT GlobeNewswire
Apr-30	Helius Medical Technologies Announces Reverse Stock Split HSDT GlobeNewswire